rdf:type |
|
lifeskim:mentions |
umls-concept:C0002978,
umls-concept:C0009491,
umls-concept:C0009924,
umls-concept:C0022038,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0063817,
umls-concept:C0205100,
umls-concept:C0220812,
umls-concept:C0301630,
umls-concept:C0332306,
umls-concept:C0444504,
umls-concept:C1517945,
umls-concept:C1527178,
umls-concept:C1579762,
umls-concept:C1705938
|
pubmed:issue |
5
|
pubmed:dateCreated |
1996-7-9
|
pubmed:abstractText |
To evaluate whether meglumine-sodium-ioxaglate (Hexabrix) and iopromide (Ultravist) are identically appropriate for peripheral angiography. Outcome variables were pain, image quality and adverse events.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1438-9029
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
432-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8634406-Adult,
pubmed-meshheading:8634406-Aged,
pubmed-meshheading:8634406-Aged, 80 and over,
pubmed-meshheading:8634406-Angiography, Digital Subtraction,
pubmed-meshheading:8634406-Contrast Media,
pubmed-meshheading:8634406-Double-Blind Method,
pubmed-meshheading:8634406-Female,
pubmed-meshheading:8634406-Humans,
pubmed-meshheading:8634406-Iohexol,
pubmed-meshheading:8634406-Ioxaglic Acid,
pubmed-meshheading:8634406-Male,
pubmed-meshheading:8634406-Middle Aged,
pubmed-meshheading:8634406-Safety
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Contrast media in peripheral angiography: does cost reduction mean loss of quality and safety? A reevaluation based on a randomized double-blind comparative study of ioxaglate versus iopromide].
|
pubmed:affiliation |
Klinische Abteilung für Angiographie und Interventionelle Radiologie, AKH-Universitätskliniken Wien.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Randomized Controlled Trial
|